Breaking News

Texcell Unveils State-of-the-Art Viral Clearance Testing Facility

Will support biosafety studies for monoclonal antibodies, gene therapies, and medical devices coming to the market.

Texcell, a contract research organization (CRO) that specializes in viral testing, viral clearance, bioassays, in vivo testing, and GMP cell banking, has opened its newest testing facility in Frederick, MD.  In a statement, the company said that the new building represents a significant milestone in Texcell’s commitment to advancing the viral safety of biotherapeutics and medical devices. Designed to support simultaneous viral clearance and biosafety studies, this 27,000 square-foot facili...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters